Perioperative Management of Patients on Anticoagulant Medications: General Principles in Medicine and Surgery

  • Jessica Rimsans
  • Katelyn W. Sylvester


Patients on oral anticoagulation (OAC) requiring an invasive procedure or surgery may require interruptions to their anticoagulation regimen depending on patient- and procedure-specific factors. The risks of both thromboembolism and procedural-related bleeding need to be considered as well as provider and patient preferences. Though some dental procedures allow for continuation of OAC, other procedures may require that their anticoagulation regimen be continued at a minimized intensity, held, or switched to a temporary “bridging” agent. A plan specific to each event requires coordination with the patient, the provider overseeing the patient’s anticoagulation regimen (e.g., primary care provider, cardiologist, or other specialist) and the provider performing the surgery or invasive procedure. This chapter will focus on the periprocedural management of anticoagulants.


Periprocedural management Anticoagulation reversal Thrombosis risk assessment 


  1. 1.
    Douketis JD, Spyropoulos AC, Spender FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R, American College of Chest Physicians. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e326S–05S.CrossRefGoogle Scholar
  2. 2.
    Pototski M, Amenabar JM. Dental management of patients receiving anticoagulation or antiplatelet treatment. J Oral Sci. 2007;49(4):253–8.CrossRefGoogle Scholar
  3. 3.
    Steed MB, Swanson MT. Warfarin and newer agents: what the oral surgeon needs to know. Oral Maxillofac Surg Clin North Am. 2016;28:515–21.CrossRefGoogle Scholar
  4. 4.
    Martinez M, Tsakiris DA. Management of antithrombotic agents in oral surgery. Dent J. 2015;3:93–101.CrossRefGoogle Scholar
  5. 5.
    Ward BB, Smith MH. Dentoalveolar procedures for the anticoagulated patient: literature recommendations versus current practice. J Oral Maxillofac Surg. 2007;65:1454–60.CrossRefGoogle Scholar
  6. 6.
    Hong C, Napenas JJ, Brennan M, Furney S, Lockhart P. Risk of postoperative bleeding after dental procedures in patients on warfarin: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:464–8.CrossRefGoogle Scholar
  7. 7.
    Olesen JB, Lip GYH, Hansen ML, Hansen PR, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillations: nationwide cohort study. BMJ. 2011;342:d124.CrossRefGoogle Scholar
  8. 8.
    Elad S, Marshall J, Meyerowitz C, Connoll G. Novel anticoagulants: general overview and practical considerations for dental practitioners. Oral Dis. 2016;22:23–32.CrossRefGoogle Scholar
  9. 9.
    Ramesh Babu MR, Ramesh C, Thirumurugan K, Arun Prasad G. Deep vein thrombosis: a rate complication in oral and maxillofacial surgery: a review of two cases. Contemp Clin Dent. 2013;4(2):236–8.CrossRefGoogle Scholar
  10. 10.
    Rimsans J, Sylvester K, Fanikos J. Transitions in care—periprocedural bridging and transitions between agents. In: Dager WE, Gulseth BP, Nutescu EA, editors. ASHP anticoagulation therapy, point of care. Bethesda, MD: American Society of Health-System Pharmacists. [In Press; expected publication Spring 2017].Google Scholar
  11. 11.
    Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373:823–33.CrossRefGoogle Scholar
  12. 12.
    Dabigatran [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2015.Google Scholar
  13. 13.
    Rivaroxaban [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2015.Google Scholar
  14. 14.
    Apixaban [package insert]. Princeton, NJ: Bristol-Meyers Squibb Company; 2015.Google Scholar
  15. 15.
    Edoxaban [package insert]. Parsippany, NJ: Daiichi Sankyo Inc; 2015.Google Scholar
  16. 16.
    Schulman S, Carrier M, Lee AYY, et al. Perioperative management of dabigatran: a prospective cohort study. Circulation. 2015;132(3):167–73.CrossRefGoogle Scholar
  17. 17.
    Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood. 2012;120(15):2954–62.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Brigham and Women’s HospitalBostonUSA

Personalised recommendations